Patient Guide: A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 211 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT06161571
Status: ACTIVE_NOT_RECRUITING
Condition: NASH/MASH, NAFLD/MASLD
Phase: PHASE3

Find a Study Location Near You

This study is available at 211 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Birmingham, Alabama
  • Chandler, Arizona
  • Flagstaff, Arizona
  • • And 208 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily